Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-09-16 SCHWARTZ MARK W. President & CEO Grant or award · Stock Option (right to buy) +200,000 200,000
2014-07-28 Kivinski Margaret VP and General Counsel Grant or award · Stock Option (right to buy) +200,000 200,000
2014-06-30 Ahn Mark J President & CEO Grant or award +2,461 $2.60 $6K 116,225
2014-06-30 SCHWARTZ MARK W. EVP, Chief Operating Officer Other acquisition +2,461 $2.60 $6K 412,126
2014-06-30 HAMILTON BRIAN L EVP, Chief Medical Officer Other acquisition +2,461 $2.60 $6K 2,461
2014-06-30 Dunlap Ryan VP, Chief Financial Officer Other acquisition +2,461 $2.60 $6K 7,804
2014-06-30 Ahn Mark J President & CEO Other acquisition +2,461 $2.60 $6K 116,225
2014-04-18 Einhorn Irving M. Director Grant or award · Stock Option (right to buy) +100,000 100,000
2014-02-12 Chin Richard Director Option exercise +50,000 $2.31 $116K 50,000
2014-02-12 Chin Richard Director Option exercise +100,000 $1.18 $118K 150,000
2014-02-12 Chin Richard Director Option exercise +37,500 $1.71 $64K 187,500
2014-02-12 Chin Richard Director Sale −187,500 $4.33 $812K 0
2014-02-12 Chin Richard Director Option exercise · Stock Option (right to buy) −50,000 0
2014-02-12 Chin Richard Director Option exercise · Stock Option (right to buy) −100,000 0
2014-02-12 Chin Richard Director Option exercise · Stock Option (right to buy) −37,500 12,500
2014-02-07 Nisi Rudolph Director Purchase +20,000 $4.94 $99K 23,500
2014-02-03 GALLIKER STEPHEN S Director Option exercise +50,000 $2.31 $116K 60,000
2014-02-03 GALLIKER STEPHEN S Director Option exercise +100,000 $1.18 $118K 160,000
2014-02-03 GALLIKER STEPHEN S Director Option exercise +50,000 $0.85 $43K 210,000
2014-02-03 GALLIKER STEPHEN S Director Option exercise +50,000 $0.72 $36K 260,000

Page 13 of 17 · 324 trades